Latest Breaking News On - Oz adler - Page 1 : vimarsana.com

SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer .

United statesTel avivOz adlerScisparc ltdMitocarex bio ltdCompany or scisparcSecurities exchangeExchange commissionForeign private issuerSecurities exchange actWallenberg streetMitocarex bioAlon silbermanPrivate securities litigation reform actAnnual reportExecutive officer

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29,.

Oz adlerCompany or scisparcSoroka medical centerExchange commissionScisparc ltdAutism spectrum disorderChief executive officerAberrant behavior checklist communityClinical global impressions improvementTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

SciSparc Delivers Treatment for Autism Spectrum Disorder

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment.

Oz adlerCompany or scisparcExchange commissionSoroka medical centerScisparc ltdAutism spectrum disorderChief executive officerAberrant behavior checklist communityClinical global impressions improvementTourette syndromeLooking statementsPrivate securities litigation reform actAnnual reportNasdaq sprcScisparc ltd

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOz adlerTrademark officeClearmind medicine incScisparc ltdCompany or scisparcExchange commissionClearmind medicinePatent cooperationUnited states patentChief executive officerTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

What s Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? - SciSparc (NASDAQ:SPRC)

SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration between the companies.

Adi zuloff shaniOz adlerBerkshire hathawayClearmind medicine incScisparc ltdBenzinga pro